Corton Capital’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$248K Buy
+17,767
New +$248K 0.29% 132
2025
Q1
Sell
-12,702
Closed -$243K 423
2024
Q4
$243K Sell
12,702
-3,103
-20% -$59.5K 0.14% 189
2024
Q3
$360K Sell
15,805
-15,927
-50% -$362K 0.17% 133
2024
Q2
$413K Buy
31,732
+12,662
+66% +$165K 0.22% 92
2024
Q1
$334K Buy
19,070
+561
+3% +$9.82K 0.12% 239
2023
Q4
$403K Buy
+18,509
New +$403K 0.13% 222